Dr. Olopade on Moving the Needle Forward in Preventive Oncology and Genetics

Video

Olufunmilayo I. Olopade, MD, FACP, discusses the need to focus efforts in preventive oncology and genetics.

Olufunmilayo Falusi Olopade, MD, FACP, director of the Center for Clinical Cancer Genetics, director of the Center for Global Health, associate dean for Global Health, and the Walter L. Palmer Distinguished Service Professor of Medicine and Human Genetics at the University of Chicago Medicine, discusses the need to focus efforts in preventive oncology and genetics.

It was an honor to be recognized as a Giant of Cancer Care® for Prevention and Genetics, says Olopade, as she has dedicated the majority of her career to bringing genetics into clinical oncology care. The oncology community has come to embrace the fact that prevention oncology is an important area where efforts should be focused, Olapade adds.

Olopade accepted her award on behalf of her colleagues who inspired her to find ways to bring genetics to the average community oncology practice; this has helped to move the needle forward over the past 25 years, she concludes.

Related Videos
Sangeeta Goswami, MD, PhD, of The University of Texas MD Anderson Cancer Center
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Andrew Ip, MD
Arya Amini, MD
Adrianna Masters, MD, PhD,
Chul Kim, MD, MPH
Andrew Ip, MD
In this final episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss a roadmap of artificial intelligence (AI) advances in the next 5 to 10 years.
In this eighth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, explain how artificial intelligence tools are being developed to match the right patient to the right drug on the right clinical trial.